Investment Rating - The investment rating for the company is "Buy" for both US and Hong Kong stocks [7]. Core Views - The company's 1Q25 performance met expectations with revenue of 46.9 billion RMB, reflecting a quarter-on-quarter increase of 4.7% and a year-on-year increase of 12.9%. The net profit attributable to shareholders was 18.0 billion RMB, which was slightly below the previous quarter but showed a significant year-on-year increase of 54.6% [1][4]. - The company is expected to maintain a cautious lending strategy, with a projected moderate growth in loan volume for 2025, supported by high-quality earnings and substantial shareholder returns [1][2]. Summary by Sections Financial Performance - 1Q25 loan volume was 889 billion RMB, showing a slight quarter-on-quarter decrease of 1.1% but a year-on-year increase of 15.8%. The loan balance reached 1,403 billion RMB, with a quarter-on-quarter increase of 2.4% and a year-on-year increase of 5.5% [2]. - The net profit take rate for 1Q25 was 5.2%, down from 5.9% in the previous quarter, indicating a potential impact on short-term profitability [3]. Risk Indicators - The C-M2 ratio increased to 0.60% in 1Q25 from 0.57% in 4Q24, while the first-day overdue rate rose to 5.0%. However, these levels remain healthy compared to historical averages [3]. - The provision coverage ratio improved to 666% from 617% in the previous quarter, indicating strong earnings quality [3]. Earnings Forecast - The company’s net profit forecasts for 2025, 2026, and 2027 have been slightly adjusted to 71 billion RMB, 77 billion RMB, and 82 billion RMB respectively, with target prices maintained at 55.6 USD for US stocks and 220.9 HKD for Hong Kong stocks [4][8].

Investment Rating - The investment rating for the company is "Buy" for both US and Hong Kong stocks [7]. Core Views - The company's 1Q25 performance met expectations with revenue of 46.9 billion RMB, reflecting a quarter-over-quarter increase of 4.7% and a year-over-year increase of 12.9%. The net profit attributable to shareholders was 18.0 billion RMB, which was slightly below the previous quarter but showed a year-over-year increase of 54.6% [1][4]. - The company is expected to maintain a cautious lending strategy, with a projected moderate growth in loan volume for 2025, supported by high-quality earnings and significant shareholder returns [1][2]. Summary by Sections Financial Performance - 1Q25 loan volume was 889 billion RMB, showing a slight quarter-over-quarter decrease of 1.1% but a year-over-year increase of 15.8%. The loan balance reached 1,403 billion RMB, with a quarter-over-quarter increase of 2.4% and a year-over-year increase of 5.5% [2]. - The net profit take rate for 1Q25 was 5.2%, down from 5.9% in the previous quarter, indicating a potential impact on short-term profitability [3]. Risk Indicators - The C-M2 ratio increased to 0.60% in 1Q25 from 0.57% in 4Q24, while the first-day overdue rate rose to 5.0% from 4.8%. Despite these increases, the risk indicators remain at healthy levels, below the average of 0.62% from 1Q21 to 4Q24 [3]. - The provision coverage ratio improved to 666% from 617% in the previous quarter, indicating strong earnings quality [3]. Earnings Forecast - The company’s net profit forecasts for 2025, 2026, and 2027 have been slightly adjusted to 71 billion RMB, 77 billion RMB, and 82 billion RMB respectively, with target prices maintained at 55.6 USD for US stocks and 220.9 HKD for Hong Kong stocks [4][8].

Investment Rating - The investment rating for the company is "Buy" with a target price of HKD 411.00 [8][9]. Core Insights - The company's 4Q24 performance met expectations, with revenue and net profit reaching HKD 63.8 billion and HKD 37.8 billion, respectively, representing year-on-year increases of 31% and 46% [1]. - The average daily trading volume (ADT) for Hong Kong stocks in 4Q24 was HKD 186.9 billion, a significant year-on-year increase of 105% [2]. - The company is expected to maintain high profitability in 1Q25 due to continued market enthusiasm and a sufficient IPO pipeline [1][2]. Summary by Sections Trading Business - 4Q24 trading revenue was HKD 37.4 billion, exceeding previous expectations, primarily due to a higher proportion of small transactions leading to a higher effective trading fee rate [2]. - The ADT for Hong Kong stocks increased significantly to HKD 186.9 billion, with derivatives and commodities showing mixed performance [2]. IPO Activity - The number of IPOs in 4Q24 rose to 26, with total financing amounting to HKD 32.4 billion, indicating a healthy IPO environment [3]. - The IPO queue reached 114 companies, suggesting a robust pipeline for future listings [3]. Investment Performance - The investment scale increased to HKD 238.6 billion by the end of 4Q24, although the overall investment yield declined to 2.1% [4]. - The company anticipates a gradual decrease in investment yields due to lower interest rates, but still expects to maintain reasonable returns in the short term [4]. Profit Forecast and Valuation - The net profit forecasts for 2025 and 2026 have been adjusted to HKD 13.9 billion and HKD 13.3 billion, respectively, reflecting a positive outlook based on active trading conditions [5]. - The target price has been revised upwards to HKD 411.00 based on a discounted cash flow (DCF) valuation method [5].